The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review
Clinical Endocrinology · 2023-04 · 98 (4) · 461-468
DOI: 10.1111/cen.14473 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Endocrinology, online erschienen am 11.04.2021. Verfasst von Petros Perros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Medically Unexplained Symptoms, Hypothyroidism. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
A significant minority of patients with hypothyroidism report persistent symptoms despite achieving normal thyroid biochemistry after levothyroxine (L‐T4) replacement. Four principal lines of thinking, which are not mutually exclusive, may explain this enigma. The ‘low tissue liothyronine hypothesis’ emphasizes the potential imperfections of L‐T4 replacement therapy that may lead to hypothyroidism in some tissues such as the brain, while others (eg hypothalamus) are euthyroid. The ‘Somatic Symptom and Related Disorders hypothesis’ draws attention to an incidental coexistence of a diagnosis of Somatic Symptom and Related Disorders in patients with treated hypothyroidism. The ‘autoimmune neuroinflammation hypothesis’ highlights the potential consequences of inflammatory mediators due to thyroid autoimmunity (the commonest cause of hypothyroidism) on the brain. The ‘comorbidities and psychosocial hypothesis’ implicates a variety of physical and psychosocial factors that have been noted to be associated with a diagnosis of hypothyroidism, which may be primarily the cause of persistent complaints. Over the past twenty years, a great deal of time and effort has been expended pursuing the ‘low tissue liothyronine hypothesis’, which has failed to yield results that translate to patient benefits. This has skewed the balance in clinical practice, in favour of pursuing answers relating to L‐T4 and liothyronine combination treatment, while the alternative explanations have been downplayed and potentially useful interventions have been given insufficient attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
- Department of Health Sciences, HYMS, University of York, York, UK.
- Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Albano, Rome, Italy.
- Division of Endocrinology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
- Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
- Department of Endocrinology, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Petros Perros
Zitieren
APA
Perros, P., Van Der Feltz-Cornelis, C., Papini, E., Nagy, E. V., Weetman, A. P., & Hegedüs, L. (2023). The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review. Clinical Endocrinology, 98(4), 461-468. https://doi.org/10.1111/cen.14473
Vancouver
Perros P, Van Der Feltz-Cornelis C, Papini E, Nagy EV, Weetman AP, Hegedüs L. The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review. Clinical Endocrinology. 2023;98(4):461-468. doi:10.1111/cen.14473
BibTeX
@article{Perros2023,
author = {Perros, Petros and Van Der Feltz-Cornelis, Christina and Papini, Enrico and Nagy, Endre V and Weetman, Anthony P and Hegedüs, Laszlo},
title = {The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review},
journal = {Clinical Endocrinology},
year = {2023},
volume = {98},
number = {4},
pages = {461--468},
doi = {10.1111/cen.14473}
}
EUVIMED